Nathan P Wiederhold (Nathan Wiederhold)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 95

Top Venues

Antimicrobial agents and chemotherapy

Journal of clinical microbiology

Journal of fungi (Basel, Switzerland)

Pathogens (Basel, Switzerland)

University of Texas at Austin (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Texas at Austin

United States

BSC :: Biology

Publications

Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng, Philip Lewis White, Mridu Sinha, Martin Hoenigl, Stephanie I Fraley
Universal digital high-resolution melting for the detection of pulmonary mold infections. Journal of clinical microbiology (2024)
Althea Campuzano, Komali Devi Pentakota, Yu-Rou Liao, Hao Zhang, Nathan P Wiederhold, Gary R Ostroff, Chiung Yu Hung
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides . Vaccines 12 (1) (2024)
Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng, Philip Lewis White, Mridu Sinha, Martin Hoenigl, Stephanie I Fraley
Universal digital high-resolution melting for the detection of pulmonary mold infections. Journal of clinical microbiology (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology 62 (4) (2024)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, Laura K Najvar, Katyna Borroto-Esoda, Thomas F Patterson, Scott G Filler, Nathan P Wiederhold, Ashraf S Ibrahim
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B. Antimicrobial agents and chemotherapy 68 (5) (2024)
Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng, Philip Lewis White, Mridu Sinha, Martin Hoenigl, Stephanie I Fraley
Universal digital high-resolution melting for the detection of pulmonary mold infections. Journal of clinical microbiology 62 (6) (2024)
Althea Campuzano, Komali Devi Pentakota, Yu-Rou Liao, Hao Zhang, Nathan P Wiederhold, Gary R Ostroff, Chiung Yu Hung
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides . Vaccines 12 (1) (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology 62 (4) (2024)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, Laura K Najvar, Katyna Borroto-Esoda, Thomas F Patterson, Scott G Filler, Nathan P Wiederhold, Ashraf S Ibrahim
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B. Antimicrobial agents and chemotherapy 68 (5) (2024)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, Laura K Najvar, Katyna Borroto-Esoda, Thomas F Patterson, Scott G Filler, Nathan P Wiederhold, Ashraf S Ibrahim
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B. Antimicrobial agents and chemotherapy (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology 62 (4) (2024)
Ana Espinel-Ingroff, Nathan P Wiederhold
A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin. Journal of fungi (Basel, Switzerland) 10 (5) (2024)
Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng, Philip Lewis White, Mridu Sinha, Martin Hoenigl, Stephanie I Fraley
Universal digital high-resolution melting for the detection of pulmonary mold infections. Journal of clinical microbiology 62 (6) (2024)
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger J M Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frederic Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P Wiederhold, George R Thompson Iii
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical microbiology reviews 37 (2) (2024)
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger J M Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frederic Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P Wiederhold, George R Thompson Iii
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical microbiology reviews 37 (2) (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology 62 (4) (2024)
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger J M Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frederic Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P Wiederhold, George R Thompson Iii
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical microbiology reviews 37 (2) (2024)
Ana Espinel-Ingroff, Nathan P Wiederhold
A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin. Journal of fungi (Basel, Switzerland) 10 (5) (2024)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, Laura K Najvar, Katyna Borroto-Esoda, Thomas F Patterson, Scott G Filler, Nathan P Wiederhold, Ashraf S Ibrahim
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B. Antimicrobial agents and chemotherapy 68 (5) (2024)
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, Marcos Olivo, David J Larwood, Thomas F Patterson
Evaluation of nikkomycin Z with frequent oral administration in an experimental model of central nervous system coccidioidomycosis. Microbiology spectrum (2024)
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger J M Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frederic Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P Wiederhold, George R Thompson Iii
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical microbiology reviews 37 (2) (2024)
Gerrit Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana-Alastruey Izquierdo, Barbara D Alexander, Maiken Cavling Arendrup, N Esther Babady, Feng-Yan Bai, Joan-Miquel Balada-Llasat, Andrew M Borman, Anuradha Chowdhary, Andrew Clark, Robert C Colgrove, Oliver A Cornely, Tanis C Dingle, Philippe J Dufresne, Jeff Fuller, Jean-Pierre Gangneux, Connie Gibas, Heather Glasgow, Yvonne Graser, Jacques Guillot, Andreas H Groll, Gerhard Haase, Kimberly E Hanson, Amanda Harrington, David L Hawksworth, Randall T Hayden, Martin Hoenigl, Vit Hubka, Kristie Johnson, Julianne V Kus, Ruoyu Li, Jacques F Meis, Michaela Lackner, Fanny Lanternier, Sixto M Leal, Francesca Lee, Shawn R Lockhart, Paul Luethy, Isabella Martin, Kyung J Kwon-Chung, Wieland Meyer, M Hong Nguyen, Luis Ostrosky-Zeichner, Elizabeth L Palavecino, Preeti Pancholi, Peter G Pappas, Gary W Procop, Scott A Redhead, Daniel D Rhoads, Stefan Riedel, Bryan Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vania A Vicente, Roxana G Vitale, Qi-Ming Wang, Nancy L Wengenack, Lars Westblade, Nathan P Wiederhold, Philip Lewis White, Christina M Wojewoda, Sean X Zhang
Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". Journal of clinical microbiology 62 (4) (2024)
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger J M Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frederic Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P Wiederhold, George R Thompson Iii
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical microbiology reviews (2024)
Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng, Philip Lewis White, Mridu Sinha, Martin Hoenigl, Stephanie I Fraley
Universal digital high-resolution melting for the detection of pulmonary mold infections. Journal of clinical microbiology 62 (6) (2024)
Ana Espinel-Ingroff, Nathan P Wiederhold
A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin. Journal of fungi (Basel, Switzerland) 10 (5) (2024)
Althea Campuzano, Komali Devi Pentakota, Yu-Rou Liao, Hao Zhang, Nathan P Wiederhold, Gary R Ostroff, Chiung Yu Hung
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides . Vaccines 12 (1) (2024)
Althea Campuzano, Komali Devi Pentakota, Yu-Rou Liao, Hao Zhang, Nathan P Wiederhold, Gary R Ostroff, Chiung Yu Hung
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides . Vaccines 12 (1) (2024)
Tyler Goshia, April Aralar, Nathan P Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Mridu Sinha, Aprajita Karmakar, Ankit Sharma, Rachit Shrivastava, Haoxiang Sun, Philip Lewis White, Martin Hoenigl, Stephanie I Fraley
Universal Digital High Resolution Melt for the detection of pulmonary mold infections. bioRxiv : the preprint server for biology (2023)
Olabayo H Ajetunmobi, Gina Wall, Bruna Vidal Bonifacio, Lucero A Martinez Delgado, Ashok K Chaturvedi, Laura K Najvar, Floyd L Wormley, Hoja P Patterson, Nathan P Wiederhold, Thomas F Patterson, Jose L Lopez-Ribot
High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms. Journal of fungi (Basel, Switzerland) 9 (9) (2023)
Connie F Cañete-Gibas, James Mele, Hoja P Patterson, Carmita J Sanders, Dora Ferrer, Victor Garcia, Hongxin Fan, Marjorie David, Nathan P Wiederhold
Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America. Journal of clinical microbiology (2023)
Connie F Cañete-Gibas, Hoja P Patterson, Carmita J Sanders, James Mele, Hongxin Fan, Marjorie David, Nathan P Wiederhold
Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov. Pathogens (Basel, Switzerland) 12 (4) (2023)
Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W C Boal, Monika Ehrensberger, Ryan Boyle, Melanie T Cushion
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)". Antimicrobial agents and chemotherapy 67 (2) (2023)
Tirdad T Zangeneh, William D Lainhart, Nathan P Wiederhold, Mohanad M Al-Obaidi
Coccidioides species antifungal susceptibility testing: Experience from a Large Healthcare System in the Endemic Region. Medical mycology (2023)
Connie F Cañete-Gibas, Hoja P Patterson, Carmita J Sanders, James Mele, Hongxin Fan, Marjorie David, Nathan P Wiederhold
Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov. Pathogens (Basel, Switzerland) 12 (4) (2023)
Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W C Boal, Monika Ehrensberger, Ryan Boyle, Melanie T Cushion
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)". Antimicrobial agents and chemotherapy 67 (2) (2023)
Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W C Boal, Monika Ehrensberger, Ryan Boyle, Melanie T Cushion
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)". Antimicrobial agents and chemotherapy (2023)
Arun Maji, Corinne P Soutar, Jiabao Zhang, Agnieszka Lewandowska, Brice E Uno, Su Yan, Yogesh Shelke, Ganesh Murhade, Evgeny Nimerovsky, Collin G Borcik, Andres S Arango, Justin D Lange, Jonnathan P Marin-Toledo, Yinghuan Lyu, Keith L Bailey, Patrick J Roady, Jordan T Holler, Anuj Khandelwal, Anna M SantaMaria, Hiram Sanchez, Praveen R Juvvadi, Gina Johns, Michael J Hageman, Joanna Krise, Teclegiorgis Gebremariam, Eman G Youssef, Ken Bartizal, Kieren A Marr, William J Steinbach, Ashraf S Ibrahim, Thomas F Patterson, Nathan P Wiederhold, David R Andes, Taras V Pogorelov, Charles D Schwieters, Timothy M Fan, Chad M Rienstra, Martin D Burke
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal. Nature (2023)
Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W C Boal, Monika Ehrensberger, Ryan Boyle, Melanie T Cushion
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)". Antimicrobial agents and chemotherapy 67 (2) (2023)
Connie F Cañete-Gibas, Hoja P Patterson, Carmita J Sanders, James Mele, Hongxin Fan, Marjorie David, Nathan P Wiederhold
Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov. Pathogens (Basel, Switzerland) 12 (4) (2023)
Connie F Cañete-Gibas, Hoja P Patterson, Carmita J Sanders, James Mele, Hongxin Fan, Marjorie David, Nathan P Wiederhold
Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov. Pathogens (Basel, Switzerland) 12 (4) (2023)
Apeksha N Agarwal, Blake Chandler, Steven D Dallas, Nathan P Wiederhold, Connie Cañete-Gibas, Daniel D Mais
Closing the Brief Case: Histoplasma duboisii -an Infection with a Rare Organism Presenting as an Abdominal Mass. Journal of clinical microbiology 60 (7) (2022)
Colin T McDermott, Charles J Innis, Akinyi C Nyaoke, Kathryn A Tuxbury, Julie M Cavin, E Scott Weber, Deana Edmunds, Stéphane Lair, Jill V Spangenberg, Amy L Hancock-Ronemus, Catherine A Hadfield, Leigh A Clayton, Thomas B Waltzek, Connie F Cañete-Gibas, Nathan P Wiederhold, Salvatore Frasca
Phaeohyphomycosis due to Exophiala in Aquarium-Housed Lumpfish ( Cyclopterus lumpus ): Clinical Diagnosis and Description. Pathogens (Basel, Switzerland) 11 (12) (2022)
Nathan P Wiederhold
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. Clinical chemistry 68 (1) (2022)
Laura S Burrack, Robert T Todd, Natthapon Soisangwan, Nathan P Wiederhold, Anna Selmecki
Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo . mBio 13 (4) (2022)
Hamid Badali, Connie Cañete-Gibas, Dora McCarthy, Hoja Patterson, Carmita Sanders, Marjorie P David, James Mele, Hongxin Fan, Nathan P Wiederhold
Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States. Journal of clinical microbiology 60 (5) (2022)
Apeksha N Agarwal, Blake Chandler, Steven D Dallas, Nathan P Wiederhold, Connie Cañete-Gibas, Daniel D Mais
The Brief Case: Histoplasma duboisii -an Infection with a Rare Organism Presenting as an Abdominal Mass. Journal of clinical microbiology 60 (7) (2022)
Nathan P Wiederhold
Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents. Journal of fungi (Basel, Switzerland) 8 (8) (2022)
Colin T McDermott, Charles J Innis, Akinyi C Nyaoke, Kathryn A Tuxbury, Julie M Cavin, E Scott Weber, Deana Edmunds, Stéphane Lair, Jill V Spangenberg, Amy L Hancock-Ronemus, Catherine A Hadfield, Leigh A Clayton, Thomas B Waltzek, Connie F Cañete-Gibas, Nathan P Wiederhold, Salvatore Frasca
Phaeohyphomycosis due to Exophiala in Aquarium-Housed Lumpfish ( Cyclopterus lumpus ): Clinical Diagnosis and Description. Pathogens (Basel, Switzerland) 11 (12) (2022)
Neil A R Gow, Carolyn Johnson, Judith Berman, Alix T Coste, Christina A Cuomo, David S Perlin, Tihana Bicanic, Thomas S Harrison, Nathan P Wiederhold, Michael J Bromley, Tom Chiller, Keegan Edgar
The importance of antimicrobial resistance in medical mycology. Nature communications 13 (1) (2022)
Colin T McDermott, Charles J Innis, Akinyi C Nyaoke, Kathryn A Tuxbury, Julie M Cavin, E Scott Weber, Deana Edmunds, Stéphane Lair, Jill V Spangenberg, Amy L Hancock-Ronemus, Catherine A Hadfield, Leigh A Clayton, Thomas B Waltzek, Connie F Cañete-Gibas, Nathan P Wiederhold, Salvatore Frasca
Phaeohyphomycosis due to Exophiala in Aquarium-Housed Lumpfish ( Cyclopterus lumpus ): Clinical Diagnosis and Description. Pathogens (Basel, Switzerland) 11 (12) (2022)
Colin T McDermott, Charles J Innis, Akinyi C Nyaoke, Kathryn A Tuxbury, Julie M Cavin, E Scott Weber, Deana Edmunds, Stéphane Lair, Jill V Spangenberg, Amy L Hancock-Ronemus, Catherine A Hadfield, Leigh A Clayton, Thomas B Waltzek, Connie F Cañete-Gibas, Nathan P Wiederhold, Salvatore Frasca
Phaeohyphomycosis due to Exophiala in Aquarium-Housed Lumpfish ( Cyclopterus lumpus ): Clinical Diagnosis and Description. Pathogens (Basel, Switzerland) 11 (12) (2022)
Nathan P Wiederhold, Hoja P Patterson, Carmita J Sanders, Connie Cañete-Gibas
Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species. Mycoses (2022)
James S Lewis, Nathan P Wiederhold, Morgan Hakki, George R Thompson Iii
New Perspectives on Antimicrobial Agents: Isavuconazole. Antimicrobial agents and chemotherapy 66 (9) (2022)
Kerry O'Donnell, Tom Gräfenhan, Imane Laraba, Mark Busman, Robert H Proctor, Hye-Seon Kim, Nathan P Wiederhold, David M Geiser, Keith A Seifert
Fusarium abutilonis and F. guadeloupense , two novel species in the Fusarium buharicum clade supported by multilocus molecular phylogenetic analyses. Mycologia 114 (4) (2022)
Raquel Sabino, Nathan P Wiederhold
Diagnosis from Tissue: Histology and Identification. Journal of fungi (Basel, Switzerland) 8 (5) (2022)
Nathan P Wiederhold, Laura K Najvar, Marcos Olivo, Kelsey N Morris, Hoja P Patterson, Gabriel Catano, Thomas F Patterson
Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis. Antimicrobial agents and chemotherapy 65 (6) (2021)
Hamid Badali, Hoja P Patterson, Carmita J Sanders, Barbara Mermella, Connie F C Gibas, Ashraf S Ibrahim, Karen J Shaw, Nathan P Wiederhold
Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In Vitro Activity against Members of the Fusarium oxysporum and Fusarium solani Species Complexes. Antimicrobial agents and chemotherapy 65 (6) (2021)
Devanshi Mehta, Samuel A Hofacker, Julian A Villalba, Lyn M Duncan, John A Branda, Connie Cañete-Gibas, Nathan P Wiederhold, Jenna Moran, Amir T Fathi, Steven T Chen, Jessica Cervantes, Sarah P Hammond
First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review. Open forum infectious diseases 8 (7) (2021)
Ernesto Rodríguez-Andrade, José Francisco Cano-Lira, Nathan P Wiederhold, Alba Pérez-Cantero, Josep Guarro, Alberto Miguel Stchigel
A revision of malbranchea-like fungi from clinical specimens in the United States of America reveals unexpected novelty. IMA fungus 12 (1) (2021)
Keenan Ryan, Connie Cañete-Gibas, Carmita Sanders, Nestor Sosa, Nathan P Wiederhold
Pseudocanariomyces americanus, gen. nov., sp. nov., A New Thielavia-Like Species in the Chaetomiaceae: Identification and Management of a Prosthetic Hip Infection. Mycopathologia 186 (3) (2021)
Hamid Badali, Connie Cañete-Gibas, Hoja Patterson, Carmita Sanders, Barbara Mermella, Victor Garcia, James Mele, Hongxin Fan, Nathan P Wiederhold
In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes. Mycoses 64 (7) (2021)
Nathan P Wiederhold
Review of T-2307, an Investigational Agent That Causes Collapse of Fungal Mitochondrial Membrane Potential. Journal of fungi (Basel, Switzerland) 7 (2) (2021)
Nathan P Wiederhold, Ilan S Schwartz, Thomas F Patterson, George R Thompson Iii
Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations. Antimicrobial agents and chemotherapy 65 (4) (2021)
Mohanad Al-Obaidi, Hamid Badali, Connie Cañete-Gibas, Hoja P Patterson, Nathan P Wiederhold
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature. Mycoses 64 (6) (2021)
Nathan P Wiederhold
Antifungal Susceptibility Testing: A Primer for Clinicians. Open forum infectious diseases 8 (11) (2021)
Allison R Eberly, Usha Natarjan, Amber A Milone, Marisa A Lucke, Connie F Cañete-Gibas, Nathan P Wiederhold, Nancy L Wengenack
Answer to December 2021 Photo Quiz. Journal of clinical microbiology 59 (12) (2021)
Laura Lynn Kovanda, Gabriele Sass, Marife Martinez, Karl V Clemons, Hasan Nazik, Therese M Kitt, Nathan P Wiederhold, William W Hope, David A Stevens
Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis. Antimicrobial agents and chemotherapy 65 (6) (2021)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Abdullah Alqarihi, Nathan P Wiederhold, Laura K Najvar, Thomas F Patterson, Scott G Filler, Ashraf S Ibrahim
Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis. Journal of fungi (Basel, Switzerland) 7 (4) (2021)
Allison R Eberly, Usha Natarjan, Amber A Milone, Marisa A Lucke, Connie F Cañete-Gibas, Nathan P Wiederhold, Nancy L Wengenack
Photo Quiz: You Get What You Get, and Sometimes It's Tuberculate. Journal of clinical microbiology 59 (12) (2021)
Heather L Mead, Paris S Hamm, Isaac N Shaffer, Marcus de Melo Teixeira, Christopher S Wendel, Nathan P Wiederhold, George R Thompson Iii, Raquel Muñiz-Salazar, Laura Rosio Castañón-Olivares, Paul S Keim, Carmel Plude, Joel Terriquez, John N Galgiani, Marc J Orbach, Bridget Marie Barker
Differential Thermotolerance Adaptation between Species of Coccidioides. Journal of fungi (Basel, Switzerland) 6 (4) (2020)
Sondus Alkhazraji, Teclegiorgis Gebremariam, Abdullah Alqarihi, Yiyou Gu, Zeinab Mamouei, Shakti Singh, Nathan P Wiederhold, Karen J Shaw, Ashraf S Ibrahim
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. Antimicrobial agents and chemotherapy 64 (3) (2020)
Yong Zhang, He Yang, David Turrà, Shiguo Zhou, Dilay Hazal Ayhan, Gregory A DeIulio, Li Guo, Karen Broz, Nathan P Wiederhold, Jeffrey J Coleman, Kerry O' Donnell, Ilan Youngster, Alexander J McAdam, Sergey Savinov, Terrance Shea, Sarah Young, Qiandong Zeng, Martijn Rep, Eric Pearlman, David C Schwartz, Antonio Di Pietro, Harold Corby Kistler, Li-Jun Ma
The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes. Communications biology 3 (1) (2020)
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, Marcos Olivo, Hoja Patterson, April Connell, Yoshiko Fukuda, Junichi Mitsuyama, Gabriel Catano, Thomas F Patterson
The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris. Antimicrobial agents and chemotherapy 64 (3) (2020)
Gretchen A Morrison, Jianmin Fu, Grace C Lee, Nathan P Wiederhold, Connie F Cañete-Gibas, Evelien M Bunnik, Brian L Wickes
Nanopore Sequencing of the Fungal Intergenic Spacer Sequence as a Potential Rapid Diagnostic Assay. Journal of clinical microbiology 58 (12) (2020)
Teclegiorgis Gebremariam, Sondus Alkhazraji, Abdullah Alqarihi, Nathan P Wiederhold, Karen Joy Shaw, Thomas F Patterson, Scott G Filler, Ashraf S Ibrahim
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus. Antimicrobial agents and chemotherapy 64 (6) (2020)
Minh-Vu H Nguyen, Nathan P Wiederhold, Connie Cañete-Gibas, Carmita Sanders, George R Thompson Iii
Spiromastigoides asexualis: Phylogenetic Analysis and Evaluation as a Cause of False-Positive Blastomyces DNA Probe Test Results. Journal of clinical microbiology 58 (12) (2020)
Nathan P Wiederhold
Review of the Novel Investigational Antifungal Olorofim. Journal of fungi (Basel, Switzerland) 6 (3) (2020)
Kerry O'Donnell, Abdullah M S Al-Hatmi, Takayuki Aoki, Balázs Brankovics, José Francisco Cano-Lira, Jeffrey J Coleman, G Sybren de Hoog, Antonio Di Pietro, Rasmus J N Frandsen, David M Geiser, Connie F C Gibas, Josep Guarro, Hye-Seon Kim, H Corby Kistler, Imane Laraba, John F Leslie, Manuel S López-Berges, Erik Lysøe, Jacques F Meis, Michel Monod, Robert H Proctor, Martijn Rep, Carmen Ruiz-Roldán, Adnan Šišić, Jason E Stajich, Emma T Steenkamp, Brett A Summerell, Theo A J van der Lee, Anne D van Diepeningen, Paul E Verweij, Cees Waalwijk, Todd J Ward, Brian L Wickes, Nathan P Wiederhold, Michael J Wingfield, Ning Zhang, Sean X Zhang
No to Neocosmospora: Phylogenomic and Practical Reasons for Continued Inclusion of the Fusarium solani Species Complex in the Genus Fusarium. mSphere 5 (5) (2020)
Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, Qing Zhang, Christopher M Yates, William J Hoekstra, Robert J Schotzinger, Edward P Garvey, P David Rogers
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161. Antimicrobial agents and chemotherapy 63 (10) (2019)
Nicomedes Valenzuela-Lopez, Viridiana Magaña-Dueñas, José Francisco Cano-Lira, Nathan P Wiederhold, Josep Guarro, Alberto M Stchigel
Two new species of Gloniopsis (Hysteriales, Ascomycota) from clinical specimens: Morphological and molecular characterisation. Mycoses 62 (12) (2019)
Nathan P Wiederhold, Laura K Najvar, Karen J Shaw, Rosie Jaramillo, Hoja Patterson, Marcos Olivo, Gabriel Catano, Thomas F Patterson
Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis. Antimicrobial agents and chemotherapy 63 (11) (2019)
Andrew T Nishimoto, Nathan P Wiederhold, Stephanie A Flowers, Qing Zhang, Steven L Kelly, Joachim Morschhäuser, Christopher M Yates, William J Hoekstra, Robert J Schotzinger, Edward P Garvey, P David Rogers
In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans. Antimicrobial agents and chemotherapy 63 (6) (2019)
Jeffrey M Rybak, Wenbo Ge, Nathan P Wiederhold, Josie E Parker, Steven L Kelly, P David Rogers, Jarrod R Fortwendel
Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus. mBio 10 (2) (2019)
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, Marcos Olivo, Brian L Wickes, Gabriel Catano, Thomas F Patterson
Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus. Antimicrobial agents and chemotherapy 63 (10) (2019)
Jan E Patterson, Leticia McElmeel, Nathan P Wiederhold
In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae. Open forum infectious diseases 6 (12) (2019)
Mark J Biagi, Nathan P Wiederhold, Connie Gibas, Brian L Wickes, Victoria Lozano, Susan C Bleasdale, Larry Danziger
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria. Open forum infectious diseases 6 (7) (2019)
Nathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, Elizabeth L Berkow, Rosie Jaramillo, Marcos Olivo, Edward P Garvey, Christopher M Yates, Robert J Schotzinger, Gabriel Catano, Thomas F Patterson
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris. Antimicrobial agents and chemotherapy 63 (3) (2019)
George R Thompson, Charles R Krois, Verena K Affolter, Angela D Everett, E Katarina Varjonen, Victoria R Sharon, Anil Singapuri, Michael Dennis, Ian H McHardy, Hong Sik Yoo, Dawn M Fedor, Nathan P Wiederhold, Phylicia A Aaron, Angie Gelli, Joseph L Napoli, Stephen D White
Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort. Antimicrobial agents and chemotherapy 63 (2) (2019)
Michael A Pfaller, Paul R Rhomberg, Nathan P Wiederhold, Connie Gibas, Carmita Sanders, Hongxin Fan, James Mele, Laura Lynn Kovanda, Mariana Castanheira
In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories. Antimicrobial agents and chemotherapy 62 (10) (2018)
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, Marcos Olivo, Michael Birch, Derek Law, John H Rex, Gabriel Catano, Thomas F Patterson
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis. Antimicrobial agents and chemotherapy 62 (9) (2018)
Gina Wall, Ashok K Chaturvedi, Floyd L Wormley, Nathan P Wiederhold, Hoja P Patterson, Thomas F Patterson, José L Lopez-Ribot
Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development. Antimicrobial agents and chemotherapy 62 (10) (2018)
João Paulo Zen Siqueira, Nathan P Wiederhold, Josepa Gené, Dania García, Margarete Teresa Gottardo de Almeida, Josep Guarro
Cryptic Aspergillus from clinical samples in the USA and description of a new species in section Flavipedes. Mycoses 61 (11) (2018)
Nathan P Wiederhold, Xin Xu, Amy Wang, Laura K Najvar, Edward P Garvey, Elizabeth A Ottinger, Asaf Alimardanov, Jim Cradock, Mark Behnke, William J Hoekstra, Stephen R Brand, Robert J Schotzinger, Rosie Jaramillo, Marcos Olivo, William R Kirkpatrick, Thomas F Patterson
In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy. Antimicrobial agents and chemotherapy 62 (11) (2018)
Nathan P Wiederhold, Laura K Najvar, Edward P Garvey, Stephen R Brand, Xin Xu, Elizabeth A Ottinger, Asaf Alimardanov, Jim Cradock, Mark Behnke, William J Hoekstra, Robert J Schotzinger, Rosie Jaramillo, Marcos Olivo, William R Kirkpatrick, Thomas F Patterson
The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis. Antimicrobial agents and chemotherapy 62 (9) (2018)

Nathan P Wiederhold.css-eqlu8i{font-size:small;padding-left:4px;} (Nathan Wiederhold)

Publication Activity (10 Years)

Top Topics

Top Venues

Nathan P Wiederhold (Nathan Wiederhold)